Retraction
MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways
Paper Information
Record ID:
42270
Author(s):
Journal:
Publication Date:
November 02, 2017
Retraction Date:
January 23, 2023
(2.8 years years ago)
Subjects:
Institution:
Department of Dermatology, Tangshan City Workers' Hospital, Tangshan, Hebei 063000, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/or.2023.8488Additional Notes:
see also: https://pubpeer.com/publications/D83A2D7B4743617A547894D1F573C5
Citations (29)
29
Total Citations4
Post-Retraction(13.8%)
25
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
485
Days since retraction (latest)
Silencing of circRPPH1 Inhibits the Progression of Non-Small-Cell Lung Cancer Through miR-326/ERBB4 Signal Axis
Jin Bao, Qin Zhou, Ping Tai et al. (5 authors)
Biochemical Genetics
Published: May 2024
485 days after retraction
Downregulation of<scp>microRNA</scp>‐326 enhances<scp>ZNF322A</scp>expression, transcriptional activity and tumorigenic effects in lung cancer
Shih‐Hsuan Huang, Hung‐Chia Hsieh, Jiunn‐Min Shieh et al. (5 authors)
BioFactors
Published: Aug 2023
219 days after retraction
The role of microRNA-613 and its related genes in ovarian cancer
M. M. Mohammed, Maggie M. Ramzy, Shereen S. Gaber et al. (6 authors)
The Ukrainian Biochemical Journal
Open Access
Published: Feb 2023
31 days after retraction
MicroRNAs affecting the susceptibility of melanoma cells to CD8<sup>+</sup> T cell‐mediated cytolysis
Antonino Alejandro Pane, Theresa Kordaß, Agnes Hotz‐Wagenblatt et al. (9 authors)
Clinical and Translational Medicine
Open Access
Published: Jan 2023
4 citations
4 citations
7 days after retraction
Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease
Naser Jafari, Andrew Chen, Manohar Kolla et al. (15 authors)
Advances in Cancer Biology - Metastasis
Open Access
Published: Nov 2022
7 citations
7 citations
80 days before retraction
The Role of microRNAs in Multidrug Resistance of Glioblastoma
Parvaneh Mahinfar, Behnaz Mansoori, Davoud Rostamzadeh et al. (6 authors)
Cancers
Open Access
Published: Jun 2022
29 citations
29 citations
207 days before retraction
Computational and Bioinformatics Methods for MicroRNA Gene Prediction
Ege Rıza Karagür, Şakir Akgün, Hakan Akça
Methods in molecular biology
Published: Aug 2021
8 citations
8 citations
516 days before retraction
Integrated Analysis of the Expression, Involved Functions, and Regulatory Network of RUNX3 in Melanoma
Huaxia Chen, Feng Zhang, Yanxin Liu
Combinatorial Chemistry & High Throughput Screening
Published: Aug 2021
1 citation
1 citation
525 days before retraction
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Mohammad Taheri
Frontiers in Oncology
Open Access
Published: Apr 2021
43 citations
43 citations
641 days before retraction
The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma
Bo Hu, Xiaolu Ma, Pei‐Yao Fu et al. (11 authors)
Genomics Proteomics & Bioinformatics
Open Access
Published: Mar 2021
30 citations
30 citations
677 days before retraction
<p>A Circular RNA Derived from Golgi Glycoprotein 1 mRNA Regulates <em>KRAS</em> Expression and Promotes Colorectal Cancer Progression by Targeting microRNA-622</p>
Shuhong Hao, Rongfeng Qu, Chunmei Hu et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2020
13 citations
13 citations
783 days before retraction
Downregulation of miR‐326 and its host gene β‐arrestin1 induces pro‐survival activity of E2F1 and promotes medulloblastoma growth
Evelina Miele, Agnese Pò, Angela Mastronuzzi et al. (20 authors)
Molecular Oncology
Open Access
Published: Sep 2020
12 citations
12 citations
851 days before retraction
MIR-520f Regulated Itch Expression and Promoted Cell Proliferation in Human Melanoma Cells
Mingxia Sun, Qun An, La-Mei Chen et al. (4 authors)
Dose-Response
Open Access
Published: Apr 2020
10 citations
10 citations
1027 days before retraction
Role of miR-326 in neonatal hypoxic-ischemic brain damage pathogenesis through targeting of the δ-opioid receptor
Xuan Wang, Han Zhou, Rui Cheng et al. (7 authors)
Molecular Brain
Open Access
Published: Mar 2020
19 citations
19 citations
1029 days before retraction
Development and validation of autophagy‐related‐gene biomarker and nomogram for predicting the survival of cutaneous melanoma
Qi Wan, Lin Jin, Yaru Su et al. (6 authors)
IUBMB Life
Open Access
Published: Feb 2020
9 citations
9 citations
1067 days before retraction
miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4
Furong Nie, Q X Li, Haiyan Wei et al. (4 authors)
Neoplasma
Open Access
Published: Jan 2020
18 citations
18 citations
1118 days before retraction
<p>MiR-326: Promising Biomarker for Cancer</p>
Yao‐Jie Pan, Jian Wan, Chun‐Bin Wang
Cancer Management and Research
Open Access
Published: Dec 2019
52 citations
52 citations
1149 days before retraction
LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia
Cheng Peng, Pin Lü, Jiaying Guan et al. (7 authors)
Neoplasma
Open Access
Published: Aug 2019
58 citations
58 citations
1264 days before retraction
HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma
Ying Cheng, Tongjie Cheng, Yuqing Zhao et al. (4 authors)
Cellular Signalling
Published: Aug 2019
38 citations
38 citations
1267 days before retraction
RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway
Zahra Ghaemi, Bahram M. Soltani, Seyed Javad Mowla
Frontiers in Oncology
Open Access
Published: Jul 2019
52 citations
52 citations
1273 days before retraction
Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma
Lijie Huang, Yan Wang, Jiao Chen et al. (18 authors)
Cell Death and Disease
Open Access
Published: Jul 2019
85 citations
85 citations
1299 days before retraction
The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer
Hui Jiang, Min Liang, Yanqiong Jiang et al. (10 authors)
Cancer Cell International
Open Access
Published: May 2019
57 citations
57 citations
1333 days before retraction
Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
Bo Chen, Tianshun Gao, Weiwei Yuan et al. (6 authors)
Journal of Cancer
Open Access
Published: Jan 2019
30 citations
30 citations
1483 days before retraction
The excitable signal transduction networks: movers and shapers of eukaryotic cell migration
Dhiman Sankar Pal, Xiaoguang Li, Tatsat Banerjee et al. (5 authors)
The International Journal of Developmental Biology
Open Access
Published: Jan 2019
45 citations
45 citations
1483 days before retraction
CircPUM1 promotes the malignant behavior of lung adenocarcinoma by regulating miR-326
Jingjing Chen, Shun Xu, Shuo Chen et al. (7 authors)
Biochemical and Biophysical Research Communications
Published: Dec 2018
46 citations
46 citations
1508 days before retraction
Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS‐dependent manner
Sidi Dun, Lan Gao
Journal of Biochemical and Molecular Toxicology
Published: Dec 2018
24 citations
24 citations
1514 days before retraction
miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1
Xuan Liang, Zhaolun Li, Qunli Men et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2018
40 citations
40 citations
1586 days before retraction
miR‑30a‑5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4
Erbiao Liu, Xiyan Sun, Jin‐Ping Li et al. (4 authors)
Molecular Medicine Reports
Open Access
Published: Jun 2018
23 citations
23 citations
1684 days before retraction
PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis.
Gang Yu, Weili Sun, Yong Shen et al. (7 authors)
PubMed
Published: Jan 2018
15 citations
15 citations
1848 days before retraction
Quick Stats
Total Citations:
29
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025